Coaching and AI Create Switching Costs

The coaching layer matters because it turns Numan from a place to get a prescription into a place where treatment is actively managed every week. In practice, patients message coaches, ask the AI assistant about side effects and routines, review blood markers in the app, and get medication plus follow up in one flow. That creates more reasons to stay than a lower touch prescription marketplace, especially in weight loss where success depends on adherence, dosing changes, and habit change over months.

• Numan bundles one to one coach messaging, clinician side effect management, structured behavior change, and scheduled blood testing into its weight loss plans. Leaving Numan means not just changing pharmacy, but also rebuilding the care routine and history around the medication.
  1 sacra
• A close European comparable is Yazen, which also combines GLP-1 treatment with coaches, dietitians, psychologists, app tracking, and a maintenance phase after initial weight loss. This shows that in obesity telehealth, behavioral support is part of the product, not an add on.
  2 sacra
• This is increasingly important as medication access gets easier. Larger players like Ro have also built GLP-1 subscriptions around labs, titration, and coaching, because once branded drug supply normalizes, the durable differentiation shifts toward ongoing care and engagement rather than simple access.
  3 sacra 4 sacra

The next step is for these touchpoints to become the main retention engine as drug prices and supply become less differentiated. Numan can use coaching, AI assistance, diagnostics, and newer categories like women's hormonal health to keep extending the same recurring care relationship across more conditions and for longer patient lifecycles.